Atumnus LLC — the founding entity of endogenic pharmacology.
The Chief Executive Officer of Atumnus LLC leads the institutional, commercial, and partnership strategy of the founding entity, with primary responsibility for the patent portfolio, licensing relationships, and the institutional reference at endogenicpharmacology.com. Prior work spans health-and-longevity product development, regulatory navigation, and the commercial translation of biomedical research.
The Chief Technology Officer of Atumnus LLC leads the scientific, technical, and infrastructure architecture of the founding entity, with primary responsibility for the bioregulator composition portfolio, the formulation technology base, and the operational systems that support the discipline's clinical and commercial translation. Background spans full-stack engineering, autonomous and assistive adaptive intelligence systems, and the integrated infrastructure that ties scientific, clinical, and commercial operations into a coherent institutional program.
“Endogenic pharmacology is the natural extension of the pharmaceutical sciences into the next century of medicine. Where the first century mastered exogenous intervention, the next will master endogenous regulation. We are honored to found this discipline and to provide the canonical framework for its growth.”